A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.
A new type of painkiller aimed at treating pain from an injury or surgery has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, also known by its brand name Journavx, ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.